Furthermore, we validated the assessment of plasma CXCL12 levels in amyotrophic lateral sclerosis, providing a cost-effective and non-invasive alternative suitable for broader use, particularly in serial collections. Here, CXCL12 is linked to amyotrophic lateral sclerosis.